Stockreport

Utah Medical Products Second Quarter 2024 Earnings: EPS: US$0.98 (vs US$1.16 in 2Q 2023) [Yahoo! Finance]

Utah Medical Products, Inc.  (UTMD) 
US:NASDAQ Investor Relations: utahmed.com/investor.htm
PDF Net income: US$3.45m (down 18% from 2Q 2023). Profit margin: 33% (in line with 2Q 2023). EPS: US$0.98 (down from US$1.16 in 2Q 2023). All figures shown in the cha [Read more]